<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">9306941</PMID>
        <DateCompleted>
            <Year>1997</Year>
            <Month>10</Month>
            <Day>16</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>05</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0021-9746</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>50</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>1997</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical pathology</Title>
                <ISOAbbreviation>J. Clin. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>591-5</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">Breast tumours with a DNA content higher than 4N (hypertetraploidy) are not well characterised. The aim of this study was to evaluate the clinical and biological characteristics of 51 hypertetraploid breast carcinomas selected from a series of 860 consecutive cases analysed by flow cytometry.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The clinicopathological characteristics of the hypertetraploid group were compared with those of a control group of 138 non-hypertetraploid breast carcinomas. Breast tumours from patients submitted to surgery as primary therapeutic approach (15 hypertetraploid and the 138 non-hypertetraploid) were TNM staged and classified according to the histological type and grade. The remaining 36 patients had advanced neoplastic disease at presentation and were classified by cytological criteria only. DNA flow cytometric analysis was performed on fresh-frozen samples stained with propidium iodide. Hormone receptors were analysed by immunocytochemistry.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of hypertetraploid breast tumours was 5.9% (51 of 860). All the patients were women and the mean age at diagnosis was 65 years. There was a family history of breast cancer in 21.6% of cases. In the group of operated patients, 33.3% had pT3 tumours and 53.3% had axillary lymph node metastases. All but one tumour were invasive ductal carcinomas; the remaining was an invasive papillary carcinoma. Ten (66.7%) tumours were classified as poorly differentiated carcinomas. Oestrogen and progesterone receptors were negative in 33 (64.7%) and 38 (74.5%) tumours, respectively. At last follow up, 35 (72.9%) patients were alive, while 13 (27.1%) died of disease within three years of diagnosis. Statistical comparison of the clinicopathological features of hypertetraploid v non-hypertetraploid breast carcinomas yielded a significant difference in tumour size (p &lt; 0.001), histological grade (p &lt; 0.001), hormone receptor status (p &lt; 0.001), and overall survival (p &lt; 0.001) between the two groups.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Flow cytometric DNA hypertetraploidy is related to clinicopathological features of breast cancer usually associated with unfavourable prognosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pinto</LastName>
                    <ForeName>A E</ForeName>
                    <Initials>AE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Patologia Morfológica, Instituto Português de Oncologia de Francisco, Gentil, Lisboa, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>André</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nogueira</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mendonça</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soares</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Clin Pathol</MedlineTA>
            <NlmUniqueID>0376601</NlmUniqueID>
            <ISSNLinking>0021-9746</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004273">DNA, Neoplasm</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011980">Receptors, Progesterone</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004273" MajorTopicYN="N">DNA, Neoplasm</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011003" MajorTopicYN="Y">Ploidies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011980" MajorTopicYN="N">Receptors, Progesterone</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>1997</Year>
                <Month>7</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>1997</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>1997</Year>
                <Month>7</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">9306941</ArticleId>
            <ArticleId IdType="pmc">PMC500065</ArticleId>
            <ArticleId IdType="doi">10.1136/jcp.50.7.591</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 1990 Mar 1;65(5):1194-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2406011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pathol. 1992 Dec;168(4):357-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1484317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1990 Apr 12;322(15):1045-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2320064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 1974 Feb;60(2):523-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4855906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1976 Oct 1;194(4260):23-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">959840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 1981 Jun;75(6):816-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6167159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1981 Aug 15;48(4):980-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7272940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Histochem Cytochem. 1982 Sep;30(9):967-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6182188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 1982 Dec;78(6):806-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7148748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1983 Mar;3(5):328-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6839881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1984 Oct 15;54(8):1586-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6478400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Surg. 1987 Feb;74(2):133-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3815031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1987 Mar;8(2):225-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3582068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1987 Sep 1;47(17):4729-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3621170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1988 Feb 1;61(3):420-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3338012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1988 Nov 15;62(10):2183-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3179930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1989 Jan 1;63(1):181-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2910416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1989 Jan;10(1):56-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2917476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1989 Mar 9;320(10):627-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2918874</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1989 Nov 1;64(9):1894-900</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2790700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 1990 Apr;93(4):471-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2321579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1990 Jul 15;66(2):331-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2164437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1991 Apr;15(4):358-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2006715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 1991 Nov;19(5):403-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1757079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 1992;28(2-3):504-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1591074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Oncol. 1992;31(2):157-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1622630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1993 Mar 15;71(6 Suppl):2151-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8443764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1993 Apr 15;71(8):2507-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8453574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 1993 Aug 4;85(15):1206-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8331681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1993;14(5):482-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8354119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 Jul 1;74(1 Suppl):381-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8004612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 Sep 15;74(6):1752-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8082078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 1995 Jul;70(7):678-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7791392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1995 Oct;72(4):832-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7547228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1995 Sep 1;21(1):6-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8529472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1995 Dec 15;22(4):282-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8749778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1990 Apr 1;65(7):1577-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2311069</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>